Facts and myths about radiopeptide therapy: Scylla, Charybdis and Sibyl [2]

European Journal of Nuclear Medicine

Volumn 29, Issue 8, 2002, Pages 1099-1100

  Bodei, Lisa ^a   Chinol, Marco ^a   Cremonesi, Marta ^a   Paganelli, Giovanni ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; DEXTRAN; LUTETIUM; LYSINE DERIVATIVE; OCTREOTIDE[3 TYROSINE] 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID IN 111; OCTREOTIDE[3 TYROSINE] 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID Y 86; OCTREOTIDE[3 TYROSINE] 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID Y 90; PENTETREOTIDE IN 111; PEPTIDE DERIVATIVE; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; YTTRIUM 90; (DOTA(0) PHE(1) TYR(3))OCTREOTIDE; (DOTA(0)-PHE(1)-TYR(3))OCTREOTIDE; DRUG DERIVATIVE; INDIUM; OCTREOTIDE;

CANCER CELL; CANCER RADIOTHERAPY; CELL KILLING; CLINICAL TRIAL; DOSIMETRY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; HUMAN; ISOTOPE LABELING; KIDNEY TUBULE ABSORPTION; LETTER; MAXIMUM TOLERATED DOSE; NEPHROTOXICITY; RADIATION DOSE; KIDNEY TUMOR; NOTE;

HUMAN; INDIUM RADIOISOTOPES; KIDNEY NEOPLASMS; OCTREOTIDE; RADIOTHERAPY DOSAGE; HUMANS;

EID: 0036323282     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0864-8     Document Type: Letter

References (13)

1. Between the Scylla and Charybdis of peptide radionuclide therapy: Hitting the tumor and saving the kidney
2. Nephrotoxicity versus anti-tumour efficacy in radiopeptide therapy: Facts and myths about the Scylla and Charybdis
3. Radiation dosimetry for indium-111-pentetreotide
4. 90Y-DOTATOC
5. 111In-DTPA-octreotide
6. 90Y-DOTA-D-Phe1-Tyr3-octreotide
7. 90Y-DOTA-D-Phe1-Tyr3-octreotide: The experience of the European Institute of Oncology group
8. 90Y-DOTATOC: Dosimetric evaluations
9. 111In-pentetreotide. State of the art and perspectives
10. 90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study
11. 0]octreotide in patients
12. A new cause of renal thrombotic microangiopathy: Yttrium 90-DOTATOC internal radiotherapy
13. 90Y-DOTATOC